FDA approves Sleep System (Breathe Technologies) for Obstructive Sleep Apnea

The FDA has granted Breathe Technologies 510(k) clearance to market its Sleep System (Continuous Positive Airway Pressure, or CPAP & Interface) in the US for treatment of Obstructive Sleep Apnea (OSA). The Breathe Sleep System utilises miniaturized technologies coupled with user-centric design to provide a therapeutic solution for patients with OSA. The Sleep System provides effective therapy and features a redesigned humidification system, an interactive patient touch-screen interface, and a smart pressure ramp function.